AGL vs SPCX
AGL: Agilon health partners with primary care physicians to modernize their practices and shift them toward value-based care models for Medicare Advantage populations. SPCX: A vertically integrated innovation engine combining orbital space transportation, global satellite connectivity, and a frontier AI platform.
Side-by-side fundamentals
| Metric | AGL | SPCX | Edge |
|---|---|---|---|
| Price as of 2026-10-01 close | $82.28 | $151.06 | |
| Market cap | $1.4B | $1.86T | |
| Net margin FY2025, SEC XBRL | -6.6% | n/a | |
| Operating margin FY2025, SEC XBRL | -7.8% | n/a | |
| ROE FY2025, SEC XBRL | -308.8% | n/a | |
| ROA FY2025, SEC XBRL | -30.8% | n/a | |
| Debt / equity as of 2026-09-03 | 0.13 | 0.31 | AGL lower |
| Revenue growth (YoY) as of 2026-09-03 | +0.3% | +91.9% | SPCX higher |
| Revenue CAGR (3y) SEC XBRL | +35.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-09-03 | 0.73 | 0.20 | |
| 1-year return as of 2026-10-01 close | +229.1% | +499.8% | SPCX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-01.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.